Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1615
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19371866 | FORMULATIONS COMPRISING INOSITOL, SILICATES, AND OPTIONALLY AMINO ACIDS WITH IMPROVED SOLUBILITY AND METHODS OF MAKING THE SAME | Final Rejection | Nutrition21, LLC |
| 18860504 | COMPOSITION FOR DYEING HAIR | Non-Final OA | LG H&H CO., LTD. |
| 17323392 | MULTI-CAVITY CUSTOMIZABLE DOSAGE FORMS | Non-Final OA | Kenvue Brands LLC |
| 17582616 | MINI SOFTGEL NAPROXEN COMPOSITION | Final Rejection | R.P. SCHERER TECHNOLOGIES, LLC |
| 18549652 | LIQUID VISCOELASTIC SWALLOWING AID TO PROMOTE SAFE SWALLOWING OF SOLID ORAL DOSAGE FORMS (SODF) | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18851634 | COMPOSITION SUITABLE FOR EYEBROWS | Non-Final OA | L'Oreal |
| 18683624 | PATCH AND PRODUCTION METHOD THEREOF | Final Rejection | KANEKA CORPORATION |
| 16707580 | ORAL PRODUCT AND METHOD OF MANUFACTURE | Non-Final OA | NICOVENTURES TRADING LIMITED |
| 18515897 | PHARMACEUTICAL COMPOSITIONS COMPRISING VENGLUSTAT | Final Rejection | Genzyme Corporation |
| 18853162 | BIODEGRADABLE LIPIDOIDS AND COMPOSITIONS AND METHODS OF USE THEREOF FOR LIVER TARGETED DELIVERY | Non-Final OA | The Trustees of the University of Pennsylvania |
| 17622315 | BLEND OF BEESWAX AND A LACTYLATE ESTER | Non-Final OA | SYMRISE AG |
| 18507884 | QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF | Non-Final OA | OWP Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy